These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3839397)

  • 21. Adenosine-mediated stimulation of bone cell adenylate cyclase activity.
    Peck WA; Carpenter JG; Schuster RJ
    Endocrinology; 1976 Sep; 99(3):901-9. PubMed ID: 182472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activation of adenyl cyclase from bovine brain caudate nucleus by synthetic analogs of guanyl nucleotides].
    Skurat AV; Perfil'eva EA; Baranova LA; Khropov IuV; Bulargina TV
    Biokhimiia; 1982 Oct; 47(10):1716-23. PubMed ID: 7171651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible inhibition of adenylate cyclase activity of rat brain caudate nucleus by oxidized glutathione.
    Baba A; Lee E; Matsuda T; Kihara T; Iwata H
    Biochem Biophys Res Commun; 1978 Dec; 85(3):1204-10. PubMed ID: 736960
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship of the inhibition of epinephrine-stimulated adenylate cyclase in turkey erythrocytes by adenosine to its "R-" and "P-site"-mediated effects.
    Newman ME
    Biochem Pharmacol; 1983 Jan; 32(1):37-40. PubMed ID: 6830618
    [No Abstract]   [Full Text] [Related]  

  • 25. Specific MG2+ and adenosine sites involved in a bireactant mechanism for adenylate cyclase inhibition and their probable localization on this enzyme's catalytic component.
    Premont J; Guillon G; Bockaert J
    Biochem Biophys Res Commun; 1979 Sep; 90(2):513-9. PubMed ID: 315773
    [No Abstract]   [Full Text] [Related]  

  • 26. Alteration of adenylate cyclase activity by phosphorylation and dephosphorylation.
    Akiyama T; Gotho E; Ogawara H
    Biochem Biophys Res Commun; 1983 Apr; 112(1):250-6. PubMed ID: 6838611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azido-iodo-phenyl-analogs of 2',5'-dideoxy-adenosine as photoaffinity ligands for adenylyl cyclase.
    Shoshani I; Qui H; Johnson F; Taussig R; Johnson RA
    Biochim Biophys Acta; 1995 Aug; 1245(1):37-42. PubMed ID: 7654764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular localization of adenylate cyclase in thymocytes.
    Monneron A; d'Alayer J
    Biochim Biophys Acta; 1980 Apr; 629(1):50-60. PubMed ID: 6966161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and use of 3'-(azidoiodosalicyl) derivatives of 2', 5'-dideoxyadenosine as photoaffinity ligands for adenylyl cyclase.
    Shoshani I; Taussig R; Iyengar R; Johnson RA
    Arch Biochem Biophys; 2000 Apr; 376(1):221-8. PubMed ID: 10729209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of aluminum on bovine parathyroid adenylate cyclase.
    Bellorin-Font E; Weaver ME; Stokes TJ; McConkey C; Slatopolsky E; Martin KJ
    Endocrinology; 1985 Oct; 117(4):1456-61. PubMed ID: 4029088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential roles of high and low affinity guanosine 5'-triphosphate binding sites in the regulation of follicle-stimulating hormone binding to receptor and signal transduction in bovine calf testis membranes.
    Zhang SB; Dattatreyamurty B; Reichert LE
    Endocrinology; 1991 Jan; 128(1):295-302. PubMed ID: 1898882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of adenylate cyclase by adenosine: characterization of the P-site.
    Bushfield M; Johnson RA
    Biochem Soc Trans; 1990 Apr; 18(2):150-1. PubMed ID: 2379673
    [No Abstract]   [Full Text] [Related]  

  • 33. Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
    Johnson RA; Yeung SM; Stübner D; Bushfield M; Shoshani I
    Mol Pharmacol; 1989 May; 35(5):681-8. PubMed ID: 2498637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a membrane-bound trypsin-like proteinase and seminal proteinase inhibitors on the bicarbonate-sensitive adenylate cyclase in porcine sperm plasma membranes.
    Okamura N; Onoe S; Kawakura K; Tajima Y; Sugita Y
    Biochim Biophys Acta; 1990 Jul; 1035(1):83-9. PubMed ID: 2166577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic nucleotides vs. adenosine analogs as inhibitors of adenylate cyclase activity: nonidentity of sites of action.
    Weinryb I; Michel IM
    Experientia; 1975 Aug; 31(8):892-4. PubMed ID: 169141
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific binding of a novel compound, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) to the active site of cAMP-dependent protein kinase.
    Hagiwara M; Inagaki M; Hidaka H
    Mol Pharmacol; 1987 May; 31(5):523-8. PubMed ID: 3574296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.
    Liang BT
    J Pharmacol Exp Ther; 1989 Jun; 249(3):775-84. PubMed ID: 2732946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adenylate cyclase from rabbit heart: substrate binding site].
    Perfil'eva EA; Khropov IuV; Khachatrian L; Bulargina TV; Baranova LA
    Biokhimiia; 1981 Aug; 46(8):1411-9. PubMed ID: 7272361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine sensitive adenylate cyclase inactivation by organolead compounds.
    Wilson WE
    Neurotoxicology; 1982 Jul; 3(1):100-7. PubMed ID: 6890180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
    Perez-Reyes E; Cooper DM
    Mol Pharmacol; 1987 Aug; 32(1):212-6. PubMed ID: 3112556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.